Eden Radioisotopes

Investor diligence package for a Series B raise

Investor-grade diligence package for Eden Radioisotopes' Series B raise — building the technical, market, and operating narrative for a domestic medical-isotope supplier as market volatility cut the U.S. off from the Russian-sourced isotopes it had relied on, including supply-chain mapping and downside scenarios.